Two pioneering technologies may help predict vision loss from retinopathies.
To reach elusive orbital tumors, a surgical team pioneers new micro-robotics.
More patients with low vision issues will need comprehensive support.
Can eye screening through PCPs change the paradigm for blindness prevention?
Research confirms central retinal artery occlusion brings undiagnosed risk factors for cardiovascular and cerebrovascular events.
Through a global health grant, Vanderbilt will help bring eye care to survivors.
A Vanderbilt surgeon partners with Orbis, known for its “flying” hospital, to bring training to physicians and life-changing eye care to patients in Trujillo, Peru.
1 / 5
Clinical trial results suggest new therapies could restore vision lost to LHON.
Research has suggested dosages as low as 0.01% may slow myopia progression and cause few to no side effects.
Two studies could lead to therapies to combat glaucoma and other degenerative eye diseases.